E. Bel (Amsterdam, The Netherlands), M. Gaga (Athens, Greece)
What defines abnormal lung function in asthma? Results from European community respiratory health survey (ECRHS) I. Cerveri, A. Corsico, S. Accordini, R. Niniano, E. Ansaldo, G. Cervio, C. Janson, N. Künzli, D. Jarvis, R. de Marco (Pavia, Verona, Italy; Uppsala, Sweden; Barcelona, Spain; London, United Kingdom)
| |
A treatment regime based on induced sputum eosinophilia does not result in a reduction in exacerbations in refractory severe asthmatics D. Pinot, A. Nieves, A. M. Lorec, K. Botturi, A. Cavailles, D. Breen, D. Vervloet, A. Magnan (Marseille, France)
| |
Smoking asthmatics – does smoking make them differ in disease manifestations? L. Rasmussen, V. Backer (Copenhagen, Denmark)
| |
Increased serum IL-17 is an independent risk factor for severe asthma I. Agache, L. Duca, M. Anghel (Brasov, Romania)
| |
Control of severe asthma and its relationship with satisfaction with treatment and with general health status J. L. Rodriguez Hermosa, C. Barcina, M. Calle, M. Munoz, M. Leal, M. J. Gomez, J. L. Alvarez-Sala (Madrid, Spain)
| |
Are we routinely using severity assessment in hospital admissions with acute severe asthma? W. Ahmed, S. Saha, C. J. Brook, T. Fernandez, S. Fong, R. Ali, A. Choudhury (London, Romford, United Kingdom)
| |
Improved quality of life by internet-based self-management versus usual care in asthma: a randomized controlled trial V. van der Meer, M. J. Bakker, K. F. Rabe, P. J. Sterk, J. Kievit, W. J. J. Assendelft, J. K. Sont (Leiden, Amsterdam, Netherlands)
| |